- Home
- FBRT vs ASMB Comparison
FBRT vs ASMB Comparison
Compare FBRT & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBRT | ASMB |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | United States | United States |
| Employees | 223 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.5M | 512.1M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | FBRT | ASMB |
|---|---|---|
| Price | $7.74 | $25.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $11.50 | ★ $44.20 |
| AVG Volume (30 Days) | ★ 1.1M | 138.4K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 15.83% | N/A |
| EPS Growth | N/A | ★ 91.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.34 | N/A |
| Revenue Next Year | $4.95 | $638.39 |
| P/E Ratio | $13.56 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.35 | $18.41 |
| 52 Week High | $11.84 | $39.71 |
Technical Indicators
Market Signals| Indicator | FBRT | ASMB |
|---|---|---|
| Relative Strength Index (RSI) | 39.79 | 45.06 |
| Support Level | N/A | $21.80 |
| Resistance Level | $8.41 | $30.36 |
| Average True Range (ATR) | 0.25 | 1.33 |
| MACD | -0.02 | -0.14 |
| Stochastic Oscillator | 28.12 | 18.63 |
Price Performance
Historical ComparisonAbout FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. The Company's operations are organized into two business units: (i) Commercial Real Estate Financing, and (ii) Agency Business. Its four reporting segments are as follows: The real estate debt business, The Agency Business, The commercial real estate conduit business, and The real estate owned business.
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.